Companies / Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc.

Nasdaq: ORMPCIK 1176309NEW YORK, NYoramed.com ↗

Financials · FY2025

Revenue$2.00M
Net income$64.05M
Total debt$106.58M
Cash$15.24M
Diluted EPS$1.50
Shares outstanding41.6M

Ownership

41.6M shares outstanding · as of Aug 10, 2026
12.8%10%+ / strategic
Ownership
10%+ / strategic12.83%5,335,183
Institutions21.11%8,779,634
Public float66.07%27,482,537

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Kidron NadavCEOFormerPresident and CEO · Director
8.23%3,422,243
Hexter JoshuaFormerCOO & CBO
2.79%1,160,384
Kidron MiriamFormerChief Scientific Officer · Director
2.72%1,133,138
Gabay AvrahamFormerChief Financial Officer
1.79%745,145
Mayer ArieFormerDirector
0.40%168,009
Shapiro BenjaminFormerDirector
0.30%123,220
Aghion DanielFormerDirector
0.27%113,441
Reznick YehudaFormerDirector
0.25%105,180

Institutional holders 62

View all →
HolderValue% of shares
BlackRock, Inc.$7.74M3.87%
Aquamarine Financial (Cayman) Ltd$5.62M4.74%
SB Capital Management Inc$5.42M4.57%
BML Capital Management, LLC$4.17M2.08%
Murchinson Ltd.$3.82M3.22%
Boothbay Fund Management, LLC$1.74M1.47%
State Street Corporation$1.16M0.58%
Marshall Wace, LLP$882.7K0.62%
Rathbones Group PLC$792.3K0.56%
Citadel Advisors LLC$558.7K0.47%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 30, 2026Kidron Miriam
Executive
OtherCommon Stock$1.44M-435K
-27.74%
1,133,138
2.72% of shares
low
Mar 30, 2026Kidron Nadav
CEO
OtherCommon Stock$148.3K-45K
-1.29%
3,422,243
8.23% of shares
low
Mar 17, 2026Gabay Avraham
Executive
GrantCommon Stock$0+96K
+14.77%
745,145
1.79% of shares
low
Jan 22, 2026Gabay Avraham
Executive
ExerciseCommon Stock$0+19K
+3.01%
649,256
1.56% of shares
low
Dec 31, 2025Gabay Avraham
Executive
GrantCommon Stock$0+115K
+22.32%
630,256
1.52% of shares
low
Dec 31, 2025Gabay Avraham
Executive
GrantCommon Stock$0+81K
+18.71%
515,256
1.24% of shares
low
Mar 17, 2026Hexter Joshua
Executive
GrantCommon Stock$0+96K
+9.01%
1,160,384
2.79% of shares
low
Jan 22, 2026Hexter Joshua
Executive
ExerciseCommon Stock$0+19K
+1.82%
1,064,495
2.56% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
BML Investment Partners, L.P.Passive13G/A—3,287,531—
BML Investment Partners, L.P.Passive13G/A—1,026,269—
Aquamarine Financial (Cayman) LtdPassive13G—2,047,652—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ORMP——68403P203—